Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 6.53 CAD 1.4% Market Closed
Market Cap: 2.4B CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+31%
Operating Income
Forecast
+23%
Net Income
Forecast
+36%

Wall Street
Price Targets

BHC Price Targets Summary
Bausch Health Companies Inc

Wall Street analysts forecast BHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BHC is 10.2 CAD with a low forecast of 10.1 CAD and a high forecast of 10.5 CAD.

BHC Lowest Forecast
Wall Street Target
10.1 CAD
55% Upside
BHC Average Forecast
Wall Street Target
10.2 CAD
56% Upside
BHC Highest Forecast
Wall Street Target
10.5 CAD
61% Upside
Lowest
Price Target
10.1 CAD
55% Upside
Average
Price Target
10.2 CAD
56% Upside
Highest
Price Target
10.5 CAD
61% Upside
Bausch Health Companies Inc Competitors:
Price Targets
4746
Formosa Laboratories Inc
74% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
24% Upside
K
4521
Kaken Pharmaceutical Co Ltd
33% Upside
LAURUSLABS
Laurus Labs Ltd
1% Downside
4746
Formosa Laboratories Inc
74% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
24% Upside
K
4521
Kaken Pharmaceutical Co Ltd
33% Upside
LAURUSLABS
Laurus Labs Ltd
1% Downside
M
MOC
Molecure SA
123% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
23% Upside
SAN
Sanofi SA
29% Upside
234080
JW Life Science Corp
39% Upside

Revenue
Forecast

Revenue Estimate
Bausch Health Companies Inc

For the last 8 years the compound annual growth rate for Bausch Health Companies Inc's revenue is 0%. The projected CAGR for the next 3 years is 3%.

0%
Past Growth
3%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Bausch Health Companies Inc

For the last 8 years the compound annual growth rate for Bausch Health Companies Inc's operating income is 6%. The projected CAGR for the next 3 years is 27%.

6%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-57%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Bausch Health Companies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BHC intrinsic value, competitors valuation, and company profile.
DCF Valuation
BHC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BHC stock valuation using valuation multiples.
Wall Street Estimates
BHC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BHC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BHC's stock price target?
Price Target
10.2 CAD

According to Wall Street analysts, the average 1-year price target for BHC is 10.2 CAD with a low forecast of 10.1 CAD and a high forecast of 10.5 CAD.

What is Bausch Health Companies Inc's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Bausch Health Companies Inc's revenue is 0%. The projected CAGR for the next 3 years is 3%.

What is Bausch Health Companies Inc's Operating Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Bausch Health Companies Inc's operating income is 6%. The projected CAGR for the next 3 years is 27%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 255,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.